Literature DB >> 3790153

Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on intermediary metabolism in isolated rat-liver cells.

W J Vaartjes, C G De Haas, H P Haagsman.   

Abstract

In hepatocytes isolated from meal-fed rats, sodium 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) decreased the rate of lipogenesis measured as incorporation of 3H from 3H2O into glycerolipids and cholesterol. Moreover, POCA inhibited the oxidation of added oleate, whereas oleate esterification was stimulated. In hepatocytes from 24-hr-starved rats, inhibition of gluconeogenesis by POCA was observed only with gluconeogenic precursors which require pyruvate carboxylation. This inhibition was secondary to impaired oxidation of long-chain fatty acids by POCA. It is concluded that, in addition to its inhibition of long-chain fatty acid oxidation, POCA interferes with de novo synthesis of cholesterol and fatty acids. On the other hand, neither fatty acid esterification nor the conversion of oxaloacetate into glucose are affected by POCA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3790153     DOI: 10.1016/0006-2952(86)90705-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Differential effects of etomoxir treatment on cardiac Na+-K+ ATPase subunits in diabetic rats.

Authors:  Kiminori Kato; Anton Lukas; Donald C Chapman; Heinz Rupp; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

2.  Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation.

Authors:  P B Corr; M H Creer; K A Yamada; J E Saffitz; B E Sobel
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

3.  Modification of myosin isozymes and SR Ca(2+)-pump ATPase of the diabetic rat heart by lipid-lowering interventions.

Authors:  H Rupp; V Elimban; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1994-03-16       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.